Oxovanadium(iv)-based near-IR PDT agents: design to biological evaluation
- 16 February 2009
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- No. 13,p. 1703-1705
Abstract
An oxovanadium(IV) complex of dipyridophenazine, as a potent metal-based PDT agent, shows efficient DNA photocleavage activity at near-IR region and high photocytotoxicity in both UV-A and visible light in HeLa cells.Keywords
This publication has 21 references indexed in Scilit:
- Sensitization of Ruthenium Nitrosyls to Visible Light via Direct Coordination of the Dye Resorufin: Trackable NO Donors for Light-Triggered NO Delivery to Cellular TargetsJournal of the American Chemical Society, 2008
- A potent cytotoxic photoactivated platinum complexProceedings of the National Academy of Sciences, 2007
- Water soluble distyryl-boradiazaindacenes as efficient photosensitizers for photodynamic therapyChemical Communications, 2006
- Metal-based antitumour drugs in the post genomic eraDalton Transactions, 2006
- Bioinorganic Photochemistry: Frontiers and MechanismsChemical Reviews, 2005
- Interactions of Metal−Metal-Bonded Antitumor Active Complexes with DNA Fragments and DNAAccounts of Chemical Research, 2005
- Current Clinical and Preclinical Photosensitizers for Use in Photodynamic TherapyJournal of Medicinal Chemistry, 2004
- Photosensitized singlet oxygen and its applicationsCoordination Chemistry Reviews, 2002
- Squaraine Dyes for Photodynamic Therapy: Study of Their Cytotoxicity and Genotoxicity in Bacteria and Mammalian Cells¶‡Photochemistry and Photobiology, 2002
- Light scattering of human skin: A comparison between zinc(II)— phthalocyanine and photofrin II®Journal of Photochemistry and Photobiology B: Biology, 1996